Skip to content
OpenCapital
Get started

Chemed CHE Cash & Equivalents

Cash & Equivalents at other companies

HCA Healthcare logo
HCA HealthcareHCA
$940M-11.3%

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's cash & equivalents?
Chemed (CHE) reported cash & equivalents of $16.86M in Q1 2026.
How has Chemed's cash & equivalents changed year-over-year?
Chemed's cash & equivalents decreased by 90.3% year-over-year, from $173.88M to $16.86M.
What is the long-term trend for Chemed's cash & equivalents?
Over 5 years (2020 to 2025), Chemed's cash & equivalents has grown at a -14.5% compound annual growth rate (CAGR), from $162.68M to $74.52M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.